no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Antisense and RNAi: the gloves are off
|
Tuma, Rabiya |
|
2003 |
2 |
5 |
p. 185- 1 p. |
article |
2 |
Emanuel Petricoin III and Lance Liotta discuss the Clinical Proteomics Program
|
Clough, Joanne |
|
2003 |
2 |
5 |
p. 186-188 3 p. |
article |
3 |
High-throughput structural genomics and proteomics: where are we now?
|
Yon, Jeff |
|
2003 |
2 |
5 |
p. 201-207 7 p. |
article |
4 |
Patent news
|
Drysdale, Douglas |
|
2003 |
2 |
5 |
p. 225-226 2 p. |
article |
5 |
Patent update
|
D'Arcy, Julia |
|
2003 |
2 |
5 |
p. 224-225 2 p. |
article |
6 |
Positive outlook for reverse vaccinology
|
Dell, Helen |
|
2003 |
2 |
5 |
p. 184- 1 p. |
article |
7 |
Proteomics for drug target and biomarker identification
|
Jain, K.K. |
|
2003 |
2 |
5 |
p. 189-190 2 p. |
article |
8 |
Restoring energy in a power crisis: mitochondrial targets for drug development
|
Howell, Neil |
|
2003 |
2 |
5 |
p. 208-216 9 p. |
article |
9 |
RNAi knocks down mouse tumour growth
|
Tuma, Rabiya |
|
2003 |
2 |
5 |
p. 183- 1 p. |
article |
10 |
Target validation through high throughput proteomics analysis
|
Flook, Paul K. |
|
2003 |
2 |
5 |
p. 217-223 7 p. |
article |
11 |
The status of structural genomics
|
Bourne, Philip E. |
|
2003 |
2 |
5 |
p. 181-182 2 p. |
article |
12 |
Use of random ribozyme libraries for the rapid screening of apoptosis- and metastasis-related genes
|
Nelson, Laura D. |
|
2003 |
2 |
5 |
p. 191-200 10 p. |
article |